Navigation Links
German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device
Date:7/19/2011

s. Gieseke is a prime example of how someone who was in declining health can lead a fulfilling life with end stage heart failure."

The DuraHeart LVAS is the latest-generation rotary blood pump designed for long-term patient support.  The system incorporates a centrifugal flow rotary pump with the magnetically levitated impeller. The pump features three position sensors and electromagnetic coils that suspend the impeller inside the pump chamber without a single contact point. The impeller's active magnetic levitation is designed to eliminate friction by allowing a wide gap between blood contacting surfaces, enabling blood to flow through the pump unimpeded in a smooth, non-turbulent fashion.

The DuraHeart LVAS carries a CE Mark and is currently available for sale in Japan and Europe.  DuraHeart is limited to investigational use only in the United States.  For more information about heart failure, Ventricular Assist Devices or the DuraHeart LVAS, visit www.terumoheart.com.

About Heart Failure

More than 22 million people suffer from heart failure worldwide with approximately one million new patients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization.  The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants annually, but less than 3,000 receive a transplant each year.  A large number of people who suffer from severe heart failure do not qualify for transplantation due to other health issues. An alternative for these patients is access to artificial mechanical assist.

About Terumo Heart, Inc.

Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in Ann Arbor, Michigan.  The company's focus is t
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
5. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
6. Award-Winning Medical Technology From Germany
7. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
8. Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
9. Tekia Enters Into Distribution Agreement With Fritz Ruck/T-MED, Germany to Market Its Accommodative Intraocular Lens to Treat Presbyopia
10. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
11. German District Court Finds RENASYS™ GO NPWT System Non-infringing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire/ ... market research report is available in ... Guidebook for Application and Approval of ... to Practices (2014 Edition) ... Now, Chinese regulations on ...
(Date:8/27/2014)... R.I. , Aug. 27, 2014  CVS Caremark ... entered into a new clinical affiliation with MedStar Health, ... Maryland and the ... to high-quality, affordable health care services for patients. Through ... have access to clinical support, medication counseling, chronic disease ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... and Drug Administration (FDA) has granted priority review designation ... (HF). Ivabradine is an oral drug that inhibits the ... the sinoatrial node, the body,s cardiac pacemaker. 1 ... effects on myocardial contractility or ventricular repolarization. 1 ...
Breaking Medicine Technology:Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... Inc. (NASDAQ - YDNT) today announced that it will broadcast ... web cast conference call on Thursday, October 20, 2011 at ... call will be available through InterCall at http://tinyurl.com/YI-Quarter32011 . ... through the Company,s website, www.ydnt.com . ...
... CEO Yaacov Shoham today announced the following order. ... many new markets, including Australia-a most important market for IDenta,s ... 2000 detectors from the Australian representative GK Solutions Pty ... several months we have been in continuous contact with this ...
Cached Medicine Technology:Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2International Drug & Explosives Detection Company IDenta Corp. Receives Order From Australia 2
(Date:8/27/2014)... BRIC Laparoscopes Market Outlook to 2020 , ... data on the BRIC Laparoscopes market. The report provides ... and average prices (in US dollars) within market segments ... Video Laparoscopes), Robotic Surgical Systems and Rigid Tip Non-Video ... the patient with laparoscopic surgery versus the more common, ...
(Date:8/27/2014)... ANS is pleased to announce the availability ... the treatment of recurrent glioblastoma (GBM). Experts at ANS ... and will begin extending this new treatment option for ... a portable, non-invasive anti-mitotic system approved for use in ... It is a treatment option for patients with recurrent ...
(Date:8/27/2014)... Ticket Down is a dependable source for authentic Brazil ... The Brazilian national soccer team will tangle with the ... Stadium in Miami Gardens, Florida. The two South American ... earlier this year when Brazil got the 2-1 win, but ... announced earlier this week that Neymar would return from injury ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Power morcellator ... U.S. courts on behalf of women who allegedly experienced ... Bernstein Liebhard LLP reports. According to court documents, one ... 18th in the U.S. District Court, Northern District of ... claims the use of a power morcellator manufactured Karl ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 ... intensity focused ultrasound (HIFU), announced record-setting sales of 15 ... a steady worldwide surge in demand for the company’s ... see the results our team has achieved over the ... the Fall, which has historically been our most active ...
Breaking Medicine News(10 mins):Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer 2Health News:Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer 3Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2
... Barbara, Calif.) Scientists at UC Santa Barbara have discovered ... disease and may open up new targets for drug discovery. ... culture to finding out how they work with mice. ... Journal of Neuroscience , the scientists describe important activities of ...
... LOUIS, Feb. 5 The most recent survey ... the physician shortage,is taking a toll on hospital ... changing tactics and personnel to combat the lack,of ... Louis-based PracticeMatch,Services has officially released results from their ...
... Ill., Feb 5 Stephens Media LLC of,Las ... America of,Lisle, Illinois to deliver Surgery Benefit Management ... superior quality surgical care and,personal savings through Healthplace ... To date, the Healthplace,Surgery Benefit(TM) is the ...
... found 2 popular cholesterol-lowering drugs had little effect on ... have clearly proven their mettle against heart disease, but ... a new animal study shows. , "We certainly didn,t ... in the division of cancer prevention at the National ...
... leading companies have developed and staffed an internal ... of economic adversity, as costs are scrutinized, the ... questioned. Although internal consulting organizations are typically created ... and take on additional responsibilities supporting important executive ...
... Inc. (Nasdaq: MSON ), a developer of ... is used for the ablation of tumors and worldwide ... release second quarter fiscal year 2009 financial results on ... President and Chief Executive Officer and Richard Zaremba, Senior ...
Cached Medicine News:Health News:UCSB scientists make headway in understanding Alzheimer's disease 2Health News:UCSB scientists make headway in understanding Alzheimer's disease 3Health News:PracticeMatch: Healthcare Survey Defines Physician Recruitment Challenges 2Health News:Stephens Media LLC Partners With Healthplace America to Enhance Employee Healthcare Benefits With Quality and Savings for Surgery 2Health News:Stephens Media LLC Partners With Healthplace America to Enhance Employee Healthcare Benefits With Quality and Savings for Surgery 3Health News:Stephens Media LLC Partners With Healthplace America to Enhance Employee Healthcare Benefits With Quality and Savings for Surgery 4Health News:Statins Don't Cut Cancer Risk 2Health News:New Study Provides Benchmarks for Best Practices for Valuing Internal Consulting Organizations 2Health News:Misonix Schedules Second Quarter Fiscal Year 2009 Financial Results Conference Call; February 9, 2009 at 4:30 P.M. Eastern 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: